Litcius/Paper detail

Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome

Fei Li Kuang, Michelle Makiya, JeanAnne Ware, Lauren Wetzler, Celeste M. Nelson, Thomas Brown, Paneez Khoury, Amy D. Klion

2025The Journal of Allergy and Clinical Immunology In Practice8 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBenralizumabHypereosinophilic syndromeInternal medicinePDGFRAOncologyEosinophiliaMepolizumabEosinophilAsthmaStromal cellGiSTEosinophilic Disorders and SyndromesEosinophilic EsophagitisParvovirus B19 Infection Studies
Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome | Litcius